Brian Piper insider trades

Open-market stock purchases and sales by Brian Piper, EVP, Chief Financial Officer at Sana Biotechnology, Inc, from SEC Form 4 filings since Apr 15, 2016.

Recent trades

DateStockTradeValue
Feb 17, 2026SANA Sana Biotechnology, IncBought (not open market)—
Feb 17, 2026SANA Sana Biotechnology, IncBought (not open market)—

Companies traded

  • SANA Sana Biotechnology, Inc: other filings, last Feb 17, 2026
  • PRLD Prelude Therapeutics Inc: 7 sales, last Aug 25, 2021
  • GNMX Aevi Genomic Medicine, Inc: other filings, last Jun 14, 2018
  • MDGN Medgenics, Inc: other filings, last Apr 15, 2016

Get free alerts when Brian Piper files a new trade →